ACTIVITY EVALUATION/ATTESTATION


Please complete the following evaluation questions to receive your certificate.

1. Please select the type of credit you are requesting:(Required)
1a. Attestation of time spent on activity:(Required)
MM slash DD slash YYYY
This field is hidden when viewing the form
1a. Attestation of time spent on activity:
2. Which of the following best describes you?(Required)

3. What is your area of specialization?(Required)

4. How many patients with MS do you treat per week?(Required)

5. Please select the extent to which you agree/disagree that the activity supported the achievement of each learning objective:

Apply the current McDonald criteria to ensure the early and accurate diagnosis of MS(Required)
Evaluate clinical measures and biomarkers of disease activity to guide decisions about treatment switching or modification(Required)
Incorporate evidence-based decision-making in therapy selection by considering disease characteristics, drug efficacy and safety profiles, and patient-related factors including comorbidities and preferences(Required)

6. Please select the extent to which you agree/disagree with the statements about our faculty:

The content was well organized and clearly presented.(Required)
The presenters were effective in delivering the material.(Required)

7. Please select the extent to which you agree/disagree that the activity achieved the following:

The content was evidence-based, objective, balanced, and free of bias.(Required)
The content was relevant to my area of professional practice.(Required)

8. Please select the extent to which you agree/disagree with the following statements.

As a result of participating in this activity, my knowledge of the following has increased:

The current McDonald criteria to ensure the early and accurate diagnosis of MS(Required)

As a result of participating in this activity, my competence and/or confidence in the following have increased:

Incorporating evidence-based decision-making in therapy selection by considering disease characteristics, drug efficacy and safety profiles, and patient-related factors including comorbidities and preferences(Required)
Evaluating clinical measures and biomarkers of disease activity to guide decisions about treatment switching or modification(Required)

As a result of participating in this activity, my performance in the following will improve:

The individualized, evidence-based diagnosis and treatment of people living with MS(Required)


9. Based upon your participation in this activity, what type of changes do you anticipate you will implement? Check all that apply.(Required)
 
 
11. How confident are you that you will be able to make your intended change(s)? are you that you will be able to make your intended changes?(Required)
 
12. Please indicate any barriers you anticipate in implementing these changes. Check all that apply.(Required)
 
13. Do you employ a team-based model in your professional practice?(Required)
 
14. What changes will you make in your role on the health care team as a result of this activity? Check all that apply.(Required)
 
15. What new team-based patient care strategies do you anticipate implementing as a result of information from this activity? Check all that apply.(Required)
 
16. Were you provided with disclosure of relevant financial relationships of all persons affecting the content of this activity?(Required)
17. Were the commercial supporters of this activity acknowledged in course materials?(Required)
18. Were product names avoided in this activity, or if used, were all products referenced by their generic name?(Required)
 


Please complete the required information below. If you're choosing to receive credit, it will be emailed to the address you put into the email address field.

Your Name(Required)
Your Address(Required)